Back to Results
First PageMeta Content
EC 1.1.1 / HPGD / Nicotinamide adenine dinucleotide / 15-hydroxyprostaglandin dehydrogenase / Enzyme / NAD(P)H dehydrogenase / 1H / Prostaglandin / Short-chain dehydrogenase / Chemistry / Biology / Chemical kinetics


Probe Report: Potent and selective inhibitors of NAD+-dependent 15-hydroxyprostaglandin dehydrogenase (HPGD)
Add to Reading List

Document Date: 2012-11-29 20:05:50

Open Document

File Size: 1,86 MB

Share Result on Facebook

Company

Agilent Technologies / Aldrich Chemical Co. / Sigma Aldrich / COX / /

Currency

pence / NAD / /

Event

FDA Phase / /

Facility

University of Oxford / Medical Center Dr. / University of Oxford PubChem Summary Bioassay Identifier / /

IndustryTerm

Chemical shifts / chemical probe selectivity / real time kinetic mode / cofactor reaction product / treatment of a variety of disorders / treatment of cancer / qHTS protocol / chemical shift / prostaglandin-processing / nm emission fluorescence protocol / substrate/cofactor solution / downstream product / /

Organization

Medical Center / National Institute of Health / NIH Chemical Genomics Center / University of Oxford / University of Oxford PubChem Summary Bioassay Identifier / /

Person

Christopher Austin / Christopher Austin Assay Submitter / David J / /

Position

rt / /

Product

SDR36C1 / /

Technology

Chemical Genomics / 450 nm emission fluorescence protocol / qHTS protocol / Structural Genomics / /

SocialTag